ID   RFXAP_HUMAN             Reviewed;         272 AA.
AC   O00287; B2R9T8; Q5VZM6; Q8TC40;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   07-APR-2021, entry version 153.
DE   RecName: Full=Regulatory factor X-associated protein;
DE            Short=RFX-associated protein;
DE   AltName: Full=RFX DNA-binding complex 36 kDa subunit;
GN   Name=RFXAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PARTIAL PROTEIN SEQUENCE, AND
RP   INVOLVEMENT IN BLS2.
RX   PubMed=9118943; DOI=10.1093/emboj/16.5.1045;
RA   Durand B., Sperisen P., Emery P., Barras E., Zufferey M., Mach B.,
RA   Reith W.;
RT   "RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC
RT   class II deficiency.";
RL   EMBO J. 16:1045-1055(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   INVOLVEMENT IN BLS2.
RC   TISSUE=Lymphoblast;
RX   PubMed=10072068; DOI=10.1016/s1074-7613(00)80016-3;
RA   Nagarajan U.M., Louis-Plence P., DeSandro A., Nilsen R., Bushey A.,
RA   Boss J.M.;
RT   "RFX-B is the gene responsible for the most common cause of the bare
RT   lymphocyte syndrome, an MHC class II immunodeficiency.";
RL   Immunity 10:153-162(1999).
RN   [7]
RP   ERRATUM OF PUBMED:10072068.
RA   Nagarajan U.M., Louis-Plence P., DeSandro A., Nilsen R., Bushey A.,
RA   Boss J.M.;
RL   Immunity 10:399-399(1999).
RN   [8]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-198, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [9]
RP   STRUCTURE BY NMR OF 214-272, SUBUNIT, AND DOMAIN C-TERMINAL.
RX   PubMed=20732328; DOI=10.1016/j.jmb.2010.08.025;
RA   Laird K.M., Briggs L.L., Boss J.M., Summers M.F., Garvie C.W.;
RT   "Solution structure of the heterotrimeric complex between the interaction
RT   domains of RFX5 and RFXAP from the RFX gene regulatory complex.";
RL   J. Mol. Biol. 403:40-51(2010).
CC   -!- FUNCTION: Part of the RFX complex that binds to the X-box of MHC II
CC       promoters.
CC   -!- SUBUNIT: The RFX heterotetrameric complex consists of 2 molecules of
CC       RFX5 and one each of RFXAP and RFX-B/RFXANK; with each subunit
CC       representing a separate complementation group. RFX forms cooperative
CC       DNA binding complexes with X2BP and CBF/NF-Y. RFX associates with CIITA
CC       to form an active transcriptional complex.
CC       {ECO:0000269|PubMed:20732328}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The C-terminal domain is necessary for the RFX complex
CC       formation. {ECO:0000269|PubMed:20732328}.
CC   -!- PTM: Phosphorylated.
CC   -!- DISEASE: Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]: A severe
CC       combined immunodeficiency disease with early onset. It is characterized
CC       by a profound defect in constitutive and interferon-gamma induced MHC
CC       II expression, absence of cellular and humoral T-cell response to
CC       antigen challenge, hypogammaglobulinemia and impaired antibody
CC       production. The consequence include extreme susceptibility to viral,
CC       bacterial and fungal infections. {ECO:0000269|PubMed:10072068,
CC       ECO:0000269|PubMed:9118943}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=RFXAPbase; Note=RFXAP mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/RFXAPbase/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y12812; CAA73338.1; -; Genomic_DNA.
DR   EMBL; AK313912; BAG36635.1; -; mRNA.
DR   EMBL; AL159973; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08575.1; -; Genomic_DNA.
DR   EMBL; BC026088; AAH26088.1; -; mRNA.
DR   CCDS; CCDS9359.1; -.
DR   RefSeq; NP_000529.1; NM_000538.3.
DR   PDB; 2KW3; NMR; -; C=214-272.
DR   PDBsum; 2KW3; -.
DR   SMR; O00287; -.
DR   BioGRID; 111926; 16.
DR   CORUM; O00287; -.
DR   IntAct; O00287; 7.
DR   STRING; 9606.ENSP00000255476; -.
DR   iPTMnet; O00287; -.
DR   PhosphoSitePlus; O00287; -.
DR   BioMuta; RFXAP; -.
DR   EPD; O00287; -.
DR   jPOST; O00287; -.
DR   MassIVE; O00287; -.
DR   MaxQB; O00287; -.
DR   PaxDb; O00287; -.
DR   PeptideAtlas; O00287; -.
DR   PRIDE; O00287; -.
DR   ProteomicsDB; 47822; -.
DR   Antibodypedia; 8059; 183 antibodies.
DR   DNASU; 5994; -.
DR   Ensembl; ENST00000255476; ENSP00000255476; ENSG00000133111.
DR   GeneID; 5994; -.
DR   KEGG; hsa:5994; -.
DR   UCSC; uc001uvu.2; human.
DR   CTD; 5994; -.
DR   DisGeNET; 5994; -.
DR   GeneCards; RFXAP; -.
DR   HGNC; HGNC:9988; RFXAP.
DR   HPA; ENSG00000133111; Low tissue specificity.
DR   MalaCards; RFXAP; -.
DR   MIM; 209920; phenotype.
DR   MIM; 601861; gene.
DR   neXtProt; NX_O00287; -.
DR   OpenTargets; ENSG00000133111; -.
DR   Orphanet; 572; Immunodeficiency by defective expression of MHC class II.
DR   PharmGKB; PA34358; -.
DR   VEuPathDB; HostDB:ENSG00000133111.3; -.
DR   eggNOG; ENOG502S2J4; Eukaryota.
DR   GeneTree; ENSGT00390000006573; -.
DR   HOGENOM; CLU_084944_0_0_1; -.
DR   InParanoid; O00287; -.
DR   OMA; VSKTCTY; -.
DR   OrthoDB; 1504851at2759; -.
DR   PhylomeDB; O00287; -.
DR   TreeFam; TF332759; -.
DR   PathwayCommons; O00287; -.
DR   SIGNOR; O00287; -.
DR   BioGRID-ORCS; 5994; 14 hits in 994 CRISPR screens.
DR   ChiTaRS; RFXAP; human.
DR   EvolutionaryTrace; O00287; -.
DR   GeneWiki; RFXAP; -.
DR   GenomeRNAi; 5994; -.
DR   Pharos; O00287; Tbio.
DR   PRO; PR:O00287; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; O00287; protein.
DR   Bgee; ENSG00000133111; Expressed in female gonad and 192 other tissues.
DR   Genevisible; O00287; HS.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IPI:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 1.20.120.1340; -; 1.
DR   IDEAL; IID00425; -.
DR   InterPro; IPR038308; RFXAP_C_sf.
DR   InterPro; IPR029316; RFXAP_RFXANK-bd.
DR   PANTHER; PTHR15110; PTHR15110; 1.
DR   Pfam; PF15289; RFXA_RFXANK_bdg; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; DNA-binding; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; SCID; Ubl conjugation.
FT   CHAIN           1..272
FT                   /note="Regulatory factor X-associated protein"
FT                   /id="PRO_0000097310"
FT   REGION          214..270
FT                   /note="C-terminal domain"
FT   MOTIF           163..178
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        38..41
FT                   /note="Poly-Ala"
FT   COMPBIAS        171..178
FT                   /note="Poly-Lys"
FT   CROSSLNK        198
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CONFLICT        5
FT                   /note="G -> S (in Ref. 5; AAH26088)"
FT                   /evidence="ECO:0000305"
FT   HELIX           226..237
FT                   /evidence="ECO:0007744|PDB:2KW3"
FT   HELIX           242..258
FT                   /evidence="ECO:0007744|PDB:2KW3"
SQ   SEQUENCE   272 AA;  28232 MW;  A6757F5F03D5F905 CRC64;
     MEAQGVAEGA GPGAASGVPH PAALAPAAAP TLAPASVAAA ASQFTLLVMQ PCAGQDEAAA
     PGGSVGAGKP VRYLCEGAGD GEEEAGEDEA DLLDTSDPPG GGESAASLED LEDEETHSGG
     EGSSGGARRR GSGGGSMSKT CTYEGCSETT SQVAKQRKPW MCKKHRNKMY KDKYKKKKSD
     QALNCGGTAS TGSAGNVKLE ESADNILSIV KQRTGSFGDR PARPTLLEQV LNQKRLSLLR
     SPEVVQFLQK QQQLLNQQVL EQRQQQFPGT SM
//
